Single‐Dose Pharmacokinetics of Valganciclovir in HIV‐ and CMV‐Seropositive Subjects
- 1 August 1999
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 39 (8) , 800-804
- https://doi.org/10.1177/00912709922008452
Abstract
As a result of the low oral bioavailability of ganciclovir, a prodrug was developed to improve the bioavailability of ganciclovir. This study was designed to investigate the fasting, single‐dose phar...Keywords
This publication has 5 references indexed in Scilit:
- Effect of food on high-dose oral ganciclovir disposition in HIV-positive subjects.The Journal of Clinical Pharmacology, 1999
- Oral Ganciclovir as Maintenance Treatment for Cytomegalovirus Retinitis in Patients with AIDSNew England Journal of Medicine, 1995
- Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus— and cytomegalovirus-seropositive patientsClinical Therapeutics, 1995
- Pharmacokinetic, Safety, and Antiviral Profiles of Oral Ganciclovir in Persons Infected with Human Immunodeficiency Virus: A Phase I/II StudyThe Journal of Infectious Diseases, 1995
- Human pharmacokinetics and tolerance of oral ganciclovirAntimicrobial Agents and Chemotherapy, 1987